LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Focus ObsEva is a clinical-stage biopharma focusing on women's reproductive health and pregnancy therapeutics, presenting a target market of obstetrics, fertility clinics, and maternal-fetal medicine specialists for potential collaborations, trials, and later-stage commercialization partnerships.

Funding Leverage With substantial funding of 228M and a recent CFO/CEO transition after a restructuring, there may be opportunities to engage in strategic financing conversations, co-development deals, or minority investments tied to pipeline milestones.

Leadership Transition Recent leadership changes, including a May 2023 CEO appointment and a 2026 executive shift, signal a period of strategic realignment—a window to introduce BD initiatives aligned with new growth plans and potential partnerships.

Clinical Development As a clinical-stage company advancing novel therapies, there are partnership opportunities in clinical trial support, early access programs, and pivotal study collaborations with contract research organizations and academic medical centers.

Market Positioning ObsEva’s focus on reproductive health and preterm/pregnancy therapeutics positions it to explore licensing, distribution partnerships, or strategic alliances with established OB/GYN networks, fertility clinics, and maternal health platforms seeking innovative solutions.

Similar companies to ObsEva SA

ObsEva SA Tech Stack

ObsEva SA uses 8 technology products and services including Google AdSense, WordPress, CookieYes, and more. Explore ObsEva SA's tech stack below.

Media & News

ObsEva SA's Email Address Formats

ObsEva SA uses at least 4 email formats:
ObsEva SA Email FormatsExamplePercentage
First.Last@obseva.chJohn.Doe@obseva.ch
81%
Last@obseva.chDoe@obseva.ch
19%
First.Last@obseva.comJohn.Doe@obseva.com
98%
Last.First@obseva.comDoe.John@obseva.com
2%

Frequently Asked Questions

What is ObsEva SA's stock symbol?

Minus sign iconPlus sign iconObsEva SA is a publicly traded company; the company's stock symbol is OBSVF.

What is ObsEva SA's official website and social media links?

Minus sign iconPlus sign iconObsEva SA's official website is obseva.com and has social profiles on LinkedIn.

How much revenue does ObsEva SA generate?

Minus sign iconPlus sign icon As of July 2026, ObsEva SA's annual revenue is estimated to be <$1M.

What is ObsEva SA's SIC code and NAICS code?

Minus sign iconPlus sign iconObsEva SA's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ObsEva SA have currently?

Minus sign iconPlus sign iconAs of July 2026, ObsEva SA has approximately 12 employees across 2 continents, including Europe and North America. Key team members include Vice President Chemistry, Manufacturing And Control: J. P., Senior Director Regulatory Affairs: P. M. and Pv Director: C. B. Explore ObsEva SA's employee directory with LeadIQ.

What industry does ObsEva SA belong to?

Minus sign iconPlus sign iconObsEva SA operates in the Biotechnology Research industry.

What technology does ObsEva SA use?

Minus sign iconPlus sign iconObsEva SA's tech stack includes Google AdSense, WordPress, CookieYes, Shopify, Vue.js, AOS, Microsoft Azure and New Relic.

What is ObsEva SA's email format?

Minus sign iconPlus sign iconObsEva SA's email format typically follows the pattern of First.Last@obseva.ch. Find more ObsEva SA email formats with LeadIQ.

How much funding has ObsEva SA raised to date?

Minus sign iconPlus sign icon As of July 2026, ObsEva SA has raised $228M in funding. The last funding round occurred on Aug 08, 2019 for $75M.

When was ObsEva SA founded?

Minus sign iconPlus sign iconObsEva SA was founded in 2012.
ObsEva SA logo

ObsEva SA

Biotechnology ResearchGeneva, Switzerland11-50 Employees

ObsEva SA is a biotechnology company based in Plan-les-ouates, in the Geneva region of Switzerland.
The firm operates at the clinical development stage, concentrating on new therapies for conditions that affect women's reproductive health and pregnancy.
Its aim is to advance these candidates through development with a view toward potential market introduction.

The company focuses on addressing unmet medical needs in women's reproductive health and pregnancy.
In early 2026, reports indicate a leadership transition, with the Chief Financial Officer and Interim Chief Executive Officer departing.

Section iconCompany Overview

Website
obseva.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
OBSVF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $228M

    ObsEva SA has raised a total of $228M of funding over 5 rounds. Their latest funding round was raised on Aug 08, 2019 in the amount of $75M as a Post IPO Debt.

  • <$1M

    ObsEva SA's revenue is estimated to be in the range of <$1M

Company Leadership

  • Vice President Chemistry, Manufacturing And Control at ObsEva SA
    J. P.
    Vice President Chemistry, Manufacturing And Control
    Mobile Phone
  • Senior Director Regulatory Affairs at ObsEva SA
    P. M.
    Senior Director Regulatory Affairs
    Mobile Phone
  • Pv Director at ObsEva SA
    C. B.
    Pv Director
    Mobile Phone
  • Senior Manager Regulatory Affairs at ObsEva SA
    A. P.
    Senior Manager Regulatory Affairs
    Mobile Phone
  • Sr Expert Medical Writer at ObsEva SA
    K. S.
    Sr Expert Medical Writer
    Mobile Phone

Employee Directory

  • Board Member & Executive Consultant at ObsEva SA
    L. M.
    Board Member & Executive Consultant
    Mobile Phone
  • R & D Coordinator at ObsEva SA
    I. S.
    R & D Coordinator
    Mobile Phone
  • Regulatory Affairs Associate at ObsEva SA
    B. C.
    Regulatory Affairs Associate
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.